GEO - The GEO Group, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Boca Raton,
United States
Type: Equity
GEO price evolution
GEO
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $193.85 | $267.88 | $229.94 | |
| Short term investments | ||||
| Net receivables | $367.5 | $384.07 | $356.72 | $390.02 |
| Inventory | ||||
| Total current assets | $484.5 | $490.41 | $531.49 | $528.5 |
| Long term investments | ||||
| Property, plant & equipment | $2007.27 | $2014.91 | $2026.33 | $2046.48 |
| Goodwill & intangible assets | $887.24 | $889.53 | $891.09 | |
| Total noncurrent assets | $3153.57 | $3153.02 | $3167.9 | |
| Total investments | ||||
| Total assets | $3633.29 | $3643.99 | $3684.51 | $3696.41 |
| Current liabilities | ||||
| Accounts payable | $64.53 | $76.29 | $67.82 | $64.45 |
| Deferred revenue | ||||
| Short long term debt | $49.01 | $67.67 | $80.52 | |
| Total current liabilities | $441.64 | $388.86 | $420.93 | $437.46 |
| Long term debt | $1638.69 | $1814.12 | $1794.48 | $1807.62 |
| Total noncurrent liabilities | $1974.59 | $1954.96 | $1968.63 | |
| Total debt | $1863.13 | $1862.15 | $1888.14 | |
| Total liabilities | $2317.18 | $2363.45 | $2375.89 | $2406.09 |
| Shareholders' equity | ||||
| Retained earnings | $24.39 | -$1.93 | $125.76 | $103.09 |
| Other shareholder equity | -$13.41 | -$16.97 | -$19.82 | -$16.64 |
| Total shareholder equity | $1282.05 | $1310.07 | $1291.77 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $229.94 | $206.76 | $602.81 | $347.6 |
| Short term investments | ||||
| Net receivables | $390.02 | $416.4 | $739.15 | $765.6 |
| Inventory | ||||
| Total current assets | $528.5 | $555.01 | $943.91 | $711.32 |
| Long term investments | $22.9 | |||
| Property, plant & equipment | $2046.48 | $2092.97 | $2150.03 | $2246.92 |
| Goodwill & intangible assets | $891.09 | $902.89 | $921.35 | $943 |
| Total noncurrent assets | $3167.9 | $3205.38 | $3593.5 | $3748.8 |
| Total investments | ||||
| Total assets | $3696.41 | $3760.38 | $4537.41 | $4460.13 |
| Current liabilities | ||||
| Accounts payable | $64.45 | $79.31 | $64.07 | $85.86 |
| Deferred revenue | ||||
| Short long term debt | $80.52 | $67.31 | $46.85 | $55.26 |
| Total current liabilities | $437.46 | $437.21 | $378.84 | $411.3 |
| Long term debt | $1807.62 | $1934.42 | $3015.71 | $2990.47 |
| Total noncurrent liabilities | $1968.63 | $2158.08 | $3183.55 | $3136.75 |
| Total debt | $1888.14 | $2075.53 | $3062.56 | $3045.73 |
| Total liabilities | $2406.09 | $2593.99 | $3562.39 | $3548.04 |
| Shareholders' equity | ||||
| Retained earnings | $103.09 | -$4.24 | -$175.96 | -$222.89 |
| Other shareholder equity | -$16.64 | -$15.97 | -$20.22 | -$22.59 |
| Total shareholder equity | $1291.77 | $1166.4 | $976.21 | $913.1 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $607.18 | $605.67 | ||
| Cost of revenue | $443.53 | $441.68 | ||
| Gross Profit | $163.66 | $164 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $52.2 | $53.07 | ||
| Total operating expenses | $83.51 | $84.44 | ||
| Operating income | $80.14 | $79.56 | ||
| Income from continuing operations | ||||
| EBIT | -$2.25 | $82.03 | ||
| Income tax expense | -$20.38 | $8.07 | ||
| Interest expense | $50.64 | $51.3 | ||
| Net income | ||||
| Net income | -$32.51 | $22.67 | ||
| Income (for common shares) | -$32.51 | $22.67 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2413.17 | $2376.73 | $2256.61 | $2350.1 |
| Cost of revenue | $1744.23 | $1663.73 | $1629.05 | $1778.33 |
| Gross Profit | $668.94 | $713 | $627.57 | $571.77 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $190.77 | $196.97 | $204.31 | $193.37 |
| Total operating expenses | $311.86 | $297.56 | $333.98 | $349.2 |
| Operating income | $357.08 | $415.43 | $293.58 | $222.57 |
| Income from continuing operations | ||||
| EBIT | $361.02 | $399.26 | $329.61 | $260.33 |
| Income tax expense | $35.4 | $62.9 | $122.73 | $20.46 |
| Interest expense | $218.29 | $164.55 | $129.46 | $126.84 |
| Net income | ||||
| Net income | $107.33 | $171.81 | $77.42 | $113.03 |
| Income (for common shares) | $107.33 | $171.81 | $77.42 | $113.03 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$32.51 | $22.67 | $25.23 | |
| Operating activities | ||||
| Depreciation | $31.31 | $31.36 | $31 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.13 | $5.66 | $3.01 | |
| Total cash flows from operations | $28.71 | $85.81 | $52.21 | |
| Investing activities | ||||
| Capital expenditures | -$24.41 | -$14.77 | -$22.12 | |
| Investments | $4.7 | -$2.52 | -$4.51 | |
| Total cash flows from investing | -$80.26 | -$19.7 | -$17.29 | -$22.16 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.18 | $0.56 | $0.19 | |
| Net borrowings | -$83.23 | -$23.25 | -$79.43 | |
| Total cash flows from financing | -$186.12 | -$83.1 | -$30.1 | -$79.23 |
| Effect of exchange rate | $1.14 | $1.49 | -$3 | $2.86 |
| Change in cash and equivalents | -$41.46 | -$72.6 | $35.41 | -$46.32 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $107.33 | $171.81 | $77.42 | $113.03 |
| Operating activities | ||||
| Depreciation | $125.78 | $132.93 | $135.18 | $134.68 |
| Business acquisitions & disposals | $2.41 | |||
| Stock-based compensation | $15.06 | $16.2 | $19.2 | $23.9 |
| Total cash flows from operations | $284.93 | $296.41 | $282.63 | $441.73 |
| Investing activities | ||||
| Capital expenditures | -$73 | -$90.03 | -$65.26 | -$108.66 |
| Investments | -$7.15 | -$8.43 | -$10.74 | -$7.42 |
| Total cash flows from investing | -$60.57 | $2.96 | -$53.74 | -$104.17 |
| Financing activities | ||||
| Dividends paid | -$30.49 | -$216.15 | ||
| Sale and purchase of stock | $6.15 | $0.26 | $0.3 | -$8.39 |
| Net borrowings | -$210.79 | -$698.06 | $43.54 | $130.58 |
| Total cash flows from financing | -$208.08 | -$699.1 | $11.26 | -$96.74 |
| Effect of exchange rate | -$0.26 | -$4.75 | -$3.69 | $3.57 |
| Change in cash and equivalents | $16.02 | -$404.48 | $236.47 | $244.38 |
News
Fundamentals
| Market cap | $3.83B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 139.72M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.86 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.10 |
| Quick ratio | N/A |